Ophthalmic Devices - Senegal | Statista Market Forecast

The projected revenue in Senegal's Ophthalmic Devices market market is estimated to reach US$4.77m in 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 8.41%, leading to a market volume of US$7.14m by 2029.
When comparing globally, the United States is anticipated to generate the highest revenue of US$14.00bn in 2024.
Senegal is experiencing an increased demand for advanced ophthalmic devices to address the growing prevalence of eye diseases in the country.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in Senegal is experiencing significant growth and development. Customer preferences in Senegal are driving the demand for advanced ophthalmic devices. With an increasing aging population and rising prevalence of eye diseases, there is a growing need for improved diagnostic and treatment options. Senegalese customers are seeking ophthalmic devices that are technologically advanced, reliable, and cost-effective. They value devices that can accurately diagnose and treat various eye conditions, including cataracts, glaucoma, and refractive errors. Additionally, customers in Senegal prioritize devices that are easy to use and maintain, as well as those that provide quick and accurate results. Trends in the Ophthalmic Devices market in Senegal are aligned with global trends. The market is witnessing a shift towards minimally invasive and non-invasive procedures, such as laser-assisted surgeries and advanced imaging techniques. These trends are driven by the increasing adoption of advanced technology and the desire for faster recovery times and better patient outcomes. Additionally, there is a growing demand for portable and handheld devices that can be used in remote areas or during mobile eye clinics. This trend is particularly important in Senegal, where access to healthcare facilities may be limited in certain regions. Local special circumstances in Senegal play a role in the development of the Ophthalmic Devices market. The country has a high burden of eye diseases, including cataracts and refractive errors, which are major causes of visual impairment and blindness. This creates a significant demand for ophthalmic devices that can effectively diagnose and treat these conditions. Additionally, Senegal has a growing middle class and an increasing number of private healthcare providers, which is driving the demand for advanced ophthalmic devices in the private sector. Underlying macroeconomic factors are also contributing to the development of the Ophthalmic Devices market in Senegal. The country has been experiencing steady economic growth, which has led to an increase in healthcare spending. This has allowed for the expansion and modernization of healthcare facilities, including ophthalmic clinics and hospitals. Additionally, the government of Senegal has implemented policies to improve access to healthcare services, including eye care, which has further fueled the demand for ophthalmic devices. In conclusion, the Ophthalmic Devices market in Senegal is developing rapidly due to customer preferences for advanced and reliable devices, global trends towards minimally invasive procedures and portable devices, local special circumstances such as a high burden of eye diseases and a growing middle class, and underlying macroeconomic factors including economic growth and government initiatives to improve healthcare access.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.